Coate-Nr

Coate-HP: Hemostatic agent for bleeding control

Coate-HP is one of the hemostatic agents used to control bleeding. It is a drug developed by Bayer AG in the United States of America. The main active ingredient in Coate-HP is blood clotting factor VIII, which is also known by its international name.

Blood clotting factor VIII is an important component in the blood clotting process. It plays a key role in the formation of thrombin, which in turn promotes the formation of a blood clot. In patients with bleeding disorders such as hemophilia, factor VIII levels may be insufficient. In such cases, the use of Coate-HP makes it possible to compensate for the deficiency of this factor and prevent bleeding.

Coate-HP is available in several dosage forms, including lyophilized powder for injection. Various dosages allow you to tailor treatment to the individual needs of the patient. The drug must be prepared before use according to the instructions provided by the manufacturer.

Coate-HP has several synonyms, including Actif VIII-Antihemophilic factor, Hemoctin SDT, Hemophil M, Immunat, Cohenate FS, Coate-DVI, Cryobulin TIM 3 (Human Factor VIII concentrated), Cryoprecipitate, Cryoprecipitate dry, Cryostat SD-2, Monoclat -P, Octavi, Octanate, Recombinant, Uman Kr. These names may be used in different countries or by different manufacturers to refer to the same drug.

It is important to note that the use of Coate-HP should be carried out under the supervision of a physician and in accordance with the recommendations specified in the instructions for use. Like any medicine, Coate-HP may have side effects and contraindications that must be taken into account when using it.

In conclusion, Coate-HP is a hemostatic agent used to control bleeding. It contains clotting factor VIII and is intended for patients with bleeding disorders such as hemophilia. Proper use of the drug under medical supervision helps prevent bleeding and improve the quality of life of patients.